Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,328 | -63,476 | -37,053 | -20,116 | -137,202 |
| Depreciation Amortization | 5,851 | 2,561 | 1,850 | 1,147 | 5,501 |
| Accounts receivable | 4,012 | 2,614 | 1,885 | 1,931 | 999 |
| Accounts payable and accrued liabilities | -685 | -759 | -809 | -388 | -72 |
| Other Working Capital | -6,969 | -11,694 | -5,561 | -1,026 | -6,939 |
| Other Operating Activity | 17,465 | 19,366 | 3,623 | 3,380 | 23,847 |
| Operating Cash Flow | $-64,654 | $-51,388 | $-36,065 | $-15,072 | $-113,866 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -117,310 | 25,302 | 32,347 | 27,270 | 127,952 |
| PPE Investments | 6,681 | 6,693 | 6,708 | -29 | -1,776 |
| Investing Cash Flow | $-110,629 | $31,995 | $39,055 | $27,241 | $126,176 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 174,530 | 361 | 299 | N/A | 1,136 |
| Common Stock Repurchased | -2,352 | -749 | -380 | -277 | -1,599 |
| Other Financing Activity | 16,727 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $188,905 | $-388 | $-81 | $-277 | $-463 |
| Beginning Cash Position | 57,343 | 57,343 | 57,343 | 57,343 | 45,496 |
| End Cash Position | 70,965 | 37,562 | 60,252 | 69,235 | 57,343 |
| Net Cash Flow | $13,622 | $-19,781 | $2,909 | $11,892 | $11,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,654 | -51,388 | -36,065 | -15,072 | -113,866 |
| Capital Expenditure | -56 | -44 | -29 | -29 | -1,776 |
| Free Cash Flow | -64,710 | -51,432 | -36,094 | -15,101 | -115,642 |